What Artemetrx does

Artemetrx is a web-based integrated analytics platform that transforms pharmacy and medical claims data into actionable intelligence for drug spend management. Built on more than 30 years of pharmacy benefit management expertise from its parent Pharmaceutical Strategies Group (PSG), the platform integrates pharmacy and medical claims at the individual patient level, processing approximately 1.5 billion combined claims across 22 million pharmacy lives. It operates as a product line of PSG, which was acquired by EPIC Insurance Brokers in 2023.

The platform comprises multiple specialized modules: Core for foundational spend and trend analytics; Diagnostic for issue identification; Extend for custom reporting; GeneCQ for gene therapy risk mitigation; SpecialtyCQ for specialty drug analytics; Pricing Monitor for PBM pricing guarantee compliance; Rebate Monitor for rebate contract adherence; and Plus for hands-on support services. The underlying clinical rules engine evaluates over 1,000 unique parameters including first-line therapy and diagnosis codes to identify unnecessary medication spend and fraud, waste, and abuse patterns. The platform also performs anomaly detection to flag unusual utilization patterns, such as detecting a 400% utilization spike for the specialty drug Miebo.

Artemetrx serves enterprise healthcare payers across four primary segments: health plans, employers, health systems, and labor unions. Revenue is generated through SaaS subscription and licensing fees, delivered as part of PSG's broader pharmacy consulting engagements via direct enterprise field sales. The company does not publicly disclose pricing and operates without dedicated mobile applications or public APIs, indicating a tightly coupled, consulting-led commercial model rather than a self-serve product motion.

Name

Artemetrx

Legal name

Pharmaceutical Strategies Group, LLC

Website

https://artemetrx.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

101–250 employees

Short description

Artemetrx is a web-based analytics platform that integrates pharmacy and medical claims data to manage drug spend for health plans, employers, health systems, and labor unions, operated by Pharmaceutical Strategies Group, an EPIC Insurance Brokers subsidiary.

Ownership category

akta.pro rank

Product category

Pharmacy Benefits Analytics

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Pharmacy Benefit Analytics, Reporting & Employer Consulting (HLAEAKAK)

akta.pro secondary industry

PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)

Keywords

• Pharmacy benefit analytics
• Drug spend management
• PBM contract auditing
• Specialty drug analytics
• Pharmacy claims analytics

Headquarters

HQ city

Plano

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Analytics Platform Subscription: Artemetrx is a web-based SaaS platform that provides reports, dashboards, and analytical tools for managing drug spend and trend. Revenue appears to be generated through subscription/licensing fees as part of PSG's broader consulting service offerings.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Artemetrx is an integrated web-based analytics platform that transforms pharmacy and medical claims data into actionable intelligence for managing drug spend and trend across both pharmacy and medical benefits. Built on more than 30 years of drug management expertise, the platform provides reports, dashboards, and analytical tools covering 1.5 billion claims across 22 million pharmacy lives, serving payers and benefit sponsors through PSG's consulting organization.

Product overview

Artemetrx is an integrated web-based analytics platform that transforms pharmacy and medical claims data into actionable intelligence for drug spend and trend management. The platform operates as a core system with multiple specialized modules: Core provides foundational spend and trend analytics; Diagnostic enables issue identification; Extend offers custom reporting; GeneCQ addresses gene therapy risk; Plus provides hands-on support; Pricing Monitor tracks PBM pricing guarantees; Rebate Monitor monitors rebate contract compliance; and SpecialtyCQ focuses on specialty drug analytics. Built on more than 30 years of drug management expertise, the platform covers both pharmacy and medical benefits and integrates data at the individual patient level.

Differentiator

Problem solved

Functional benefit

Brands

• Artemetrx Core: Integrated data platform for managing spend and trend with unified pharmacy and medical data.
• Artemetrx Diagnostic
• Artemetrx Extend
• GeneCQ
• Artemetrx Plus
• Pricing Monitor
• Rebate Monitor
• SpecialtyCQ

Products and services

• Artemetrx Analytics Platform Integrated web-based analytics platform that transforms pharmacy and medical claims data into actionable intelligence for managing drug spend and trend across both pharmacy and medical benefits, serving payers and benefit sponsors.
• Artemetrx Core Core analytics foundation providing standard reports, dashboards, and benchmarking across pharmacy and medical benefits for benefit sponsors.
• Artemetrx Plus Extended analytics module offering expanded reporting and insights layered on top of the Artemetrx Core platform.
• Artemetrx Diagnostic Diagnostic-focused analytics module that uncovers clinical and financial opportunities within an organization's drug spend profile.
• Artemetrx Extend Extension analytics module offering additional reporting and dashboard capabilities for deeper pharmacy and medical benefit analysis.
• Artemetrx Rebate Monitor Standalone analytics product that audits PBM rebate performance and verifies contracted pricing terms to ensure rebate accuracy.
• Artemetrx Pricing Monitor Standalone pricing analytics module that monitors PBM pricing performance and identifies contract compliance gaps.
• Artemetrx SpecialtyCQ Specialty drug analytics module focused on managing specialty drug costs, trend, and utilization as a stand-alone solution for benefit sponsors.
• Artemetrx GeneCQ Gene therapy risk mitigation solution that identifies and manages gene therapy exposure and catastrophic financial risk within a benefits population.

Quantifiable outcome

• 2.5% decrease in PMPM gross cost and $11M in savings for one large health plan
• +6 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature8 records

Partnerships

One partnership is on record.

• EPIC (Insurance Brokerage)coreStrategic or Co-development PartnerArtemetrx is a product of Pharmaceutical Strategies Group (PSG), which is an EPIC company. EPIC is a national insurance brokerage that acquired PSG, integrating Artemetrx analytics capabilities into EPIC's benefits consulting offerings for clients.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• SmithRx: SmithRx is a technology-led PBM offering transparent pricing and integrated analytics for self-funded employers, representing an emerging competitor that combines PBM administration with embedded data analytics similar to Artemetrx.

Direct peers

• EmpiRx Health: EmpiRx Health is a PBM that combines a clinically-driven model with pharmacy analytics and population health management, competing closely with Artemetrx's specialty drug and clinical optimization modules.
• Truveris: Truveris is a healthcare technology company providing PBM contract management, pharmacy benefit analytics, and audit services to employers, health plans, and labor unions — directly overlapping with Artemetrx's analytics and PBM oversight offerings.
• RxBenefits: RxBenefits provides PBM procurement, contract oversight, and clinical analytics for self-funded employers and labor unions, mirroring Artemetrx's employer-focused PBM analytics and consulting model.
• Confidio: Confidio is a pharmacy benefits consulting firm offering PBM procurement, benchmarking, and ongoing analytics oversight for employers and health plans, directly comparable to Artemetrx's consulting-enabled analytics approach.

Broad incumbents

• Express Scripts: Express Scripts is a top-three PBM (part of Cigna/Evernorth) that provides PBM services, clinical programs, and reporting to payers and employers — a broad incumbent whose internal analytics compete with third-party platforms like Artemetrx.
• CVS Caremark: CVS Caremark is one of the largest US PBMs (part of CVS Health) offering integrated PBM, specialty pharmacy, and analytics services — a broad incumbent whose captive offerings compete with Artemetrx.
• Navitus Health Solutions: Navitus is a full-service PBM with transparent pricing and clinical management offerings for health plans, employers, and government programs, providing comparable analytics-adjacent PBM services to Artemetrx's customer base.
• MedImpact Healthcare Systems: MedImpact is an independent PBM with clinical programs and analytics capabilities serving health plans, employers, and government programs — a broader incumbent that competes with Artemetrx in PBM analytics and audit.
• OptumRx: OptumRx is the largest US PBM (part of UnitedHealth Group) and increasingly offers proprietary analytics and audit tools bundled with PBM administration, making it a broad incumbent competitor in employer-side PBM analytics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/artemetrix-specialty-drug-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Artemetrx